The Rockefeller University
banner
rockefeller.edu
The Rockefeller University
@rockefeller.edu
The Rockefeller University is a world-renowned center for research and graduate education in the biomedical sciences, chemistry, bioinformatics and physics.
Pinned
Have you signed up for our science newsletter yet? Subscribe now to stay on top of the latest discoveries taking place right here at Rockefeller, delivered monthly to your inbox: https://bit.ly/34Ez7YI
A study from the Birsoy lab showed that the antioxidant glutathione, when operating inside mitochondria, is a key factor enabling tumors to spread from the breast to the lung. #RockefellerScience #YearInReview

🔗: https://bit.ly/44GfOPG
December 26, 2025 at 4:36 PM
Shortly before his death this year, James Hudspeth achieved a groundbreaking technological advancement: the ability to keep a tiny sliver of the cochlea alive and functional outside of the body for the first time. #RockefellerScience #YearInReview

🔗: https://bit.ly/49oaOlo
December 26, 2025 at 11:30 AM
The #BradyLab identified compounds that appear effective against drug-resistant bacteria using a new technique that could uncover many more antibiotics, as well as help illuminate a previously hidden microbial world. #RockefellerScience #YearInReview

🔗: https://bit.ly/4sjhV6j
December 25, 2025 at 6:26 PM
The first detailed look at how mosquitoes mate from the Vosshall lab reversed the assumption that male mosquitoes control the process, finding that a subtle female behavior dictates if mating will take place or not. #RockefellerScience #YearInReview

🔗: https://bit.ly/4huwEpL
December 25, 2025 at 12:13 PM
Neuroscientists have long posited that #memory functions like an on/off switch—either your brain remembers something or it doesn’t. The #RajasethupathyLab discovered that the truth is more complicated. #RockefellerScience #YearInReview

🔗: https://bit.ly/3MoSsrj
December 24, 2025 at 10:12 PM
The #WalzLab revealed key details about the T cell receptor, which is essential to T cell immunotherapies. The findings could expand T cell therapies, bringing their benefits to a broader group of #cancer patients. #RockefellerScience #YearInReview

🔗: https://bit.ly/3L0r3vK
December 24, 2025 at 5:21 PM
Winter break is upon us! Stay tuned as we count down the most intriguing #RockefellerScience stories of 2025. #YearInReview
December 24, 2025 at 5:01 PM
Scientific publishing has a bias against negative results and that hurts science, says Tim Fessenden, editor of @lsajournal.org, a publication of @rupress.org. Here’s how journal editors can help.
The value of publishing negative data - News
Scientific journals love news-worthy results. Editors want to publish studies with novel data that scientists will eagerly read and cite in their own work. Because of this desire for novelty, studies ...
www.rockefeller.edu
December 23, 2025 at 2:30 PM
The #RajasethupathyLab has identified a gene that improves attention, findings in @natneuro.nature.com that may lead to a novel therapeutic approach to calming the mind. The study has implications for treating #ADHD as well as autism and schizophrenia.
Researchers identify gene that calms the mind and improves attention in mice - News
Attention disorders such as ADHD involve a breakdown in our ability to separate signal from noise. As the brain is constantly bombarded with information, focus depends on its ability to filter out distractions and detect what matters. Currently used sti...
www.rockefeller.edu
December 22, 2025 at 5:15 PM
A study from the #TarakhovskyLab reveals how diapaused embryonic stem cells maintain their ability to become any cell type. This newly discovered mechanism may explain how immune cells—and even #cancer cells—can survive long periods of metabolic stress.
Some mammals can hit pause on a pregnancy. Understanding how that happens could help us treat cancer. - News
Seals give birth only when conditions are right. After mating, a female seal can delay implantation of the embryo in the uterine wall—pausing pregnancy until she senses that her fat reserves are align...
www.rockefeller.edu
December 19, 2025 at 8:59 PM
In @natureportfolio.nature.com: Researchers, including Rockefeller's own Gabriel Victora (@victora.bsky.social), are striving to understand the impact a phenomenon known as original antigenic sin has on immunity to the virus that causes the flu.
Immunological sin: how a person's earliest flu infections dictate life-long immunity
Researchers are striving to understand the impact a phenomenon known as original antigenic sin has on immunity to the virus.
www.nature.com
December 19, 2025 at 2:16 PM
Researchers in the #RavetchLab have developed a potential replacement for treating #autoimmunedisease that’s significantly more potent than intravenous immunoglobulin therapy.

Learn more in this Q&A with Jeffrey Ravetch and first author Andrew Jones: https://bit.ly/3KTnzLy
December 18, 2025 at 8:04 PM
Don't miss this Q&A with Leslie Sibener of the #RajasethupathyLab from the @simonsfoundation.org. In it, Sibener discusses her research on how our brains prioritize which memories to hold onto and which to let go.
Leslie Sibener and How Our Brains Choose Which Memories to Keep
Leslier Sibener, a member of the Simons Foundation's Simons Society of Fellows, sat down for a conversation about her work on memory.
www.simonsfoundation.org
December 17, 2025 at 7:45 PM
A new study from the #WalzLab has revealed key details about the T cell receptor, which is essential to T cell immunotherapies. The findings could refine and expand T cell therapies, bringing their benefits to a much broader group of cancer patients.
This new understanding of T cell receptors may improve cancer immunotherapies
Researchers discovered that a crucial first step in the signaling system operates differently than previously thought, an insight that could lead to the next generation of treatments.
www.rockefeller.edu
December 16, 2025 at 9:05 PM
A growing body of research, including work from Rockefeller's own @sohailtavazoie.bsky.social, suggests tumors rely on proteins and genes that are unique to the nervous system to persist in the body: https://www.nature.com/articles/d41586-025-03943-3
Pancreatic cancer is evasive. Is the nervous system the reason why?
A growing body of research suggests tumours rely on proteins and genes that are unique to the nervous system to persist in the body.
www.nature.com
December 15, 2025 at 7:29 PM
Rifampicin, the main treatment for TB, is losing ground against drug-resistant bacteria. A new study from @rocklabtb.bsky.social and Liz Campbell in @natmicrobiol.nature.com finds that pairing rifampicin with a second inhibitor dramatically boosts the potency of both drugs.
This new, one-two punch could knock out drug-resistant TB - News
Tuberculosis is both curable and preventable, yet each year, it still kills more people than any other infectious disease. One reason is that current treatments hinge on rifampicin, an antibiotic that blocks bacterial transcription and forms the corners...
www.rockefeller.edu
December 12, 2025 at 9:00 PM
The Stavros Niarchos Foundation Institute for Global Infectious Disease Research at Rockefeller aims to better understand the agents that cause infectious disease and to lower barriers to treatment and prevention globally.

Get a closer look:
The SNF Institute for Global Infectious Disease Research: A closer look
The SNF Institute for Global Infectious Disease Research: A closer look  The SNF Institute has released a short video highlighting its vital work in the field…
vimeo.com
December 11, 2025 at 6:21 PM
In creating the first reference brain for the clonal raider ant, @danielkronauer.bsky.social has discovered a surprising individuality of brain characteristics that may yield new insights into the #neuroscience of individuality within animal societies.
🔗: www.rockefeller.edu/news/38754-a...
December 10, 2025 at 7:22 PM
Rockefeller's @junyuecao.bsky.social has been named a Hevolution/@afar.org New Investigator Awardee in Aging Biology and Geroscience Research. Congratulations, Jun! https://www.afar.org/grantee-profiles/junyue-cao-1
Junyue Cao - American Federation for Aging Research
Associate Professor, The Rockefeller University. Decipher the Cell Regulatory Network of Mammalian Aging at the Scale of the Whole Organism. Aging is a
www.afar.org
December 10, 2025 at 3:28 PM
Rockefeller's Elaine Fuchs tells @knowablemag.bsky.social how animals actively reallocate their amino acid resources in times of scarcity. Her research found that when animals were deprived of serine, skin stem cells devoted less effort to making hair.
How plant-eaters snag their essential amino acids
Early in evolution, we animals lost the ability to manufacture nine of the 20 building blocks needed to make proteins. Herbivores evolved an impressive array of tricks to ensure their dietary needs are met.
knowablemagazine.org
December 9, 2025 at 9:12 PM
This #WorldSoilDay we celebrate Rockefeller's Sean Brady and his Drugs from Dirt research program, which sifts through soil samples from around the world in search of new antibiotics.

Learn more in this 2024 piece from the @newyorker.com by Dhruv Khullar:
How Machines Learned to Discover Drugs
The A.I. revolution is coming to a pharmacy near you.
www.newyorker.com
December 5, 2025 at 8:59 PM
"Even when we’re carrying out molecular studies on stem cells, my lab is always trying to look at the big picture and adjust the driving questions we ask so that we can bridge the gap between basic science and medicine."
Why understanding stem cells lies as the root of treating diseases from psoriasis to cancer - News
Your skin is in a constant state of reinvention. Every month, your body sheds and regenerates its entire outer layer--a complete turnover powered by tiny, tireless stem cells. These same cells spring into action when you get a cut, healing wounds with r...
www.rockefeller.edu
December 5, 2025 at 4:42 PM
Congrats to Yuanhuang Chen in the Sakmar lab for being awarded a predoctoral fellowship in drug discovery from the @phrmafoundation.bsky.social!
PhRMA Foundation Awards $3.6M in 2026 Drug Discovery, Delivery, and Translational Medicine Fellowships and Grants
The PhRMA Foundation awarded 50 early-career researchers a total of more than $3.6 million in 2026 fellowships and grants focused on drug discovery, drug delivery, and translational medicine research.
www.phrmafoundation.org
December 4, 2025 at 8:58 PM
New Rockefeller research from Michael Rout and Brian Chait finds that nuclear pore complex (NPC) machinery is an extraordinarily dynamic system, offering new insights into diseases such as #cancer and #neurodegeneration that are linked to NPC breakdown: https://bit.ly/3KAlrIk
December 2, 2025 at 8:58 PM